Covid-19 Vaccines
The 2026-2027 Covid-19 Vaccine was approved by the FDA on August 27, 2026. As soon as vaccine is shipped and available at our pharmacy we will open the calendar.
mnexspike by Moderna 26-27 COVID-19 VACCINE (Age 12+)
|
Underlying Conditions and Higher Risk for Severe COVID-19
For patients 12-64 you will be asked to attest to one of the following conditions.
- Asthma
- Cancer
- Cerebrovascular disease
- Chronic kidney disease
- Chronic lung diseases, limited to bronchiectasis, COPD (Chronic Obstructive Pulmonary Disease), interstitial lung disease, pulmonary embolism, pulmonary hypertension
- Chronic liver diseases, limited to cirrhosis, non-alcoholic fatty liver disease, alcoholic liver disease, autoimmune hepatitis
- Cystic fibrosis
- Diabetes mellitus, type 1 and type 2
- Disabilities, including Down syndrome (complete list included here)
- Epilepsy
- Heart conditions (such as heart failure, coronary artery disease, or cardiomyopathies)
- Hemophilia
- HIV (human immunodeficiency virus)
- Mental health conditions, limited to mood disorders (including depression), schizophrenia spectrum disorders
- Neurologic conditions, limited to dementia and Parkinson’s Disease
- Overweight (BMI >30 )
- Physical inactivity
- Pregnancy or recent pregnancy
- Primary immunodeficiencies
- Sickle cell disease
- Smoking, current or former
- Solid organ or blood stem cell transplantation
- Tuberculosis
- Use of corticosteroids or other immunosuppressive medications
|
Back to Immunizations
Back to Top